VANTAS
LOE Approachinghistrelin acetate
NDASUBCUTANEOUSIMPLANT
Approved
Oct 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 10h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VANTAS is a subcutaneous implant containing histrelin acetate, a gonadotropin-releasing hormone (GnRH) agonist approved in 2004. It is indicated for palliative treatment of advanced prostate cancer in men. The implant delivers continuous hormone suppression over 12 months by inhibiting luteinizing hormone and follicle-stimulating hormone release.
LOE Approaching
As LOE approaches, VANTAS brand teams face contraction; focus will shift to managed decline and retention of existing patient base rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer
Started Jan 2011
142 enrolled
Prostate Cancer
Career Relevance
VANTAS currently shows zero linked job openings, reflecting its LOE-approaching lifecycle stage. Career opportunities on this product are contracting; roles focus on maintaining existing market position and managing physician relationships rather than growth or launch activities.
Brand Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.